Chapter 5.3 – HIV-1-Associated Dementia

Publisher Summary This chapter discusses the role of chemokine receptors and their ligands in the disease mechanisms. HIV-1-associated dementia (HAD) results from complex interactions between viral and host factors. Four chemokine receptors and their ligands (CXCR4/SDF-1, CCR5/MIP-1α and β, RANTES, CCR2/MCP-1, and CX3CR1/fractalkine) are of particular importance in HAD. HIV-1 infection of macrophages and microglia in the CNS is primarily mediated by CCR5. A subset of strains can infect macrophages and microglia via CXCR4. Increased monocyte trafficking into the CNS of patients with HAD is likely to result from increased expression of MCP-1, in addition to CCR5 chemokines. Neurodegenerative mechanisms in HAD may involve interactions between the HIV-1 envelope glycoproteins (Env) and CXCR4, or possibly other chemokine receptors on neurons, and possibly other CNS cell types. CCR5 and CXCR4 are promising targets for the prevention and treatment of HAD. Several compounds that selectively block virus entry without affecting physiological functions of these receptors are being developed, and some are in early clinical trials. Understanding the role of CCR5, CXCR4 and other chemokine receptors and their ligands in HIV-1 neuropathogenesis will be important for advancing the development of new therapeutic strategies for the prevention and treatment of HAD and other neurological complications of HIV-1 infection.

[1]  A. Lazzarin,et al.  Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. , 1996, The Journal of infectious diseases.

[2]  M. Hirsch,et al.  Combination of CCR5 and CXCR4 Inhibitors in Therapy of Human Immunodeficiency Virus Type 1 Infection: In Vitro Studies of Mixed Virus Infections , 2000, Journal of Virology.

[3]  Sandra A. Kinnear,et al.  Neuronal Fractalkine Expression in HIV-1 Encephalitis: Roles for Macrophage Recruitment and Neuroprotection in the Central Nervous System1 , 2000, The Journal of Immunology.

[4]  R. Ransohoff,et al.  Chemokines and chemokine receptors in CNS pathology. , 1999, Journal of neurovirology.

[5]  H. Pfister,et al.  Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-γ inducible protein 10 , 1999, Journal of Neuroimmunology.

[6]  P. Pitha,et al.  Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry. , 2000, Virology.

[7]  J. Goedert,et al.  Genetic polymorphism in CX3CR1 and risk of HIV disease. , 2000, Science.

[8]  K. Peden,et al.  CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1 , 1997, Journal of virology.

[9]  Hui-yu Liu,et al.  An Orphan G Protein-Coupled Receptor, GPR1, Acts as a Coreceptor To Allow Replication of Human Immunodeficiency Virus Types 1 and 2 in Brain-Derived Cells , 1999, Journal of Virology.

[10]  Wei Zhang,et al.  CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. , 1997, The American journal of pathology.

[11]  J. McCutchan,et al.  Cerebrospinal Fluid β Chemokine Concentrations in Neurocognitively Impaired Individuals Infected with Human Immunodeficiency Virus Type 1 , 1999 .

[12]  J. Hoxie,et al.  CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons , 1997, Current Biology.

[13]  C. Broder,et al.  A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages. , 1999, Virology.

[14]  V. Sasseville,et al.  Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis. , 1998, The American journal of pathology.

[15]  E. De Clercq,et al.  Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity , 2001, Journal of Virology.

[16]  R. Doms,et al.  Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques. , 1999, Virology.

[17]  Martin S. Hirsch,et al.  Strong in Vitro Synergy Between the Fusion Inhibitor T‐20 and the CXCR4 Blocker AMD‐3100 , 2000, Journal of acquired immune deficiency syndromes.

[18]  G. Nuovo,et al.  Human Immunodeficiency Virus Type 1 T-Lymphotropic Strains Enter Macrophages via a CD4- and CXCR4-Mediated Pathway: Replication Is Restricted at a Postentry Level , 1998, Journal of Virology.

[19]  Ying Sun,et al.  The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.

[20]  P. Gregersen,et al.  Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4 , 1998, Nature.

[21]  H. Gendelman,et al.  Lymphotropic Virions Affect Chemokine Receptor-Mediated Neural Signaling and Apoptosis: Implications for Human Immunodeficiency Virus Type 1-Associated Dementia , 1999, Journal of Virology.

[22]  E. Clercq,et al.  Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4 , 1997, The Journal of experimental medicine.

[23]  Jianbin Wang,et al.  Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis. , 2000, Journal of neurovirology.

[24]  J. Clements,et al.  Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro , 1994, Journal of virology.

[25]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[26]  D. Littman.  Chemokine Receptors: Keys to AIDS Pathogenesis? , 1998, Cell.

[27]  E. Major,et al.  Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. , 1999, Virology.

[28]  J. Albert,et al.  Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype , 1997, Journal of virology.

[29]  G. Jansen,et al.  Enhanced expression of fractalkine in HIV-1 associated dementia , 2001, Journal of Neuroimmunology.

[30]  I. Grant,et al.  HIV-1 neurocognitive disorders and chemokine receptors. , 1997, AIDS (London).

[31]  U. de Girolami,et al.  Apoptosis induced by HIV-1 infection of the central nervous system. , 1996, The Journal of clinical investigation.

[32]  O. Meucci,et al.  AIDS and the brain: is there a chemokine connection? , 1999, Trends in Neurosciences.

[33]  R. Doms,et al.  Chemokine receptors as HIV coreceptors: implications and interactions. , 1998, AIDS research and human retroviruses.

[34]  R. Doms,et al.  ChemR23, a putative chemoattractant receptor, is expressed in monocyte‐derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV‐1 strains , 1998, European journal of immunology.

[35]  H. Golding,et al.  Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5 , 1999, Nature Medicine.

[36]  S. Gartner.  HIV Infection and Dementia , 2000, Science.

[37]  Miriam K. Konkel,et al.  The Orphan Seven-Transmembrane Receptor Apj Supports the Entry of Primary T-Cell-Line-Tropic and Dualtropic Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[38]  Y. Soda,et al.  Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection. , 1998, Biochemical and biophysical research communications.

[39]  E. Génin,et al.  Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. , 2000, Science.

[40]  R. Doms,et al.  HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Sodroski,et al.  HIV-1 Entry and Macrophage Inflammatory Protein-1β-mediated Signaling Are Independent Functions of the Chemokine Receptor CCR5* , 1997, The Journal of Biological Chemistry.

[42]  R. Doms,et al.  Expression and coreceptor function of APJ for primate immunodeficiency viruses. , 2000, Virology.

[43]  B. Brew,et al.  Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): evidence for neurotropic HIV variants. , 2001, Virology.

[44]  J. Weiss,et al.  HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. , 1999, Journal of immunology.

[45]  D. Weissman,et al.  Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor , 1997, Nature.

[46]  Kaposi's Sarcoma and Protection from HIV Dementia , 1998, Science.

[47]  C. Mackay,et al.  Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. , 1997, The American journal of pathology.

[48]  A. Siccardi,et al.  CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. , 1998, Journal of immunology.

[49]  C. Birch,et al.  Syncytium‐inducing phenotype and zidovudine susceptibility of HIV‐1 isolated from post‐mortem tissue , 1996, AIDS.

[50]  P. Simmonds,et al.  Mosaic Structure of the Human Immunodeficiency Virus Type 1 Genome Infecting Lymphoid Cells and the Brain: Evidence for Frequent In Vivo Recombination Events in the Evolution of Regional Populations , 1999, Journal of Virology.

[51]  C. Mackay,et al.  Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes , 1998, The Journal of experimental medicine.

[52]  E. De Clercq,et al.  Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1. , 1999, AIDS research and human retroviruses.

[53]  G. Nuovo,et al.  AIDS Dementia Is Associated with Massive, Activated HIV-1 Infection and Concomitant Expression of Several Cytokines , 1996, Molecular medicine.

[54]  Jialin Zheng,et al.  Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia , 1999, Journal of Neuroimmunology.

[55]  D. Kabat,et al.  Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor , 1997, Journal of virology.

[56]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[57]  C. Petito,et al.  Blood‐brain barrier abnormalities in acquired immunodeficiency syndrome: Immunohistochemical localization of serum proteins in postmortem brain , 1992, Annals of neurology.

[58]  S. Nisole,et al.  Spontaneous Mutations in the env Gene of the Human Immunodeficiency Virus Type 1 NDK Isolate Are Associated with a CD4-Independent Entry Phenotype , 1998, Journal of Virology.

[59]  M. Kaul,et al.  Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[60]  R. Miller,et al.  Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[61]  P. Gorry,et al.  Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines. , 2002, The Journal of infectious diseases.

[62]  P. Simmonds,et al.  Edinburgh Research Explorer Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes , 2022 .

[63]  R. Osathanondh,et al.  Apoptosis Induced by Infection of Primary Brain Cultures with Diverse Human Immunodeficiency Virus Type 1 Isolates: Evidence for a Role of the Envelope , 1999, Journal of Virology.

[64]  Cairns Js,et al.  Chemokines and HIV-1 second receptors: The therapeutic connection , 1998 .

[65]  P. Piccioli,et al.  Glial and Neuronal Cells Express Functional Chemokine Receptor CXCR4 and Its Natural Ligand Stromal Cell‐Derived Factor 1 , 1999, Journal of neurochemistry.

[66]  Hassan Mohammad Naif,et al.  Cutting Edge: Dichotomous Effects of β-Chemokines on HIV Replication in Monocytes and Monocyte-Derived Macrophages , 1998, The Journal of Immunology.

[67]  Pascal Poignard,et al.  Highly Potent RANTES Analogues either Prevent CCR5-Using Human Immunodeficiency Virus Type 1 Infection In Vivo or Rapidly Select for CXCR4-Using Variants , 1999, Journal of Virology.

[68]  Nancy Sullivan,et al.  CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro , 1997, The Journal of experimental medicine.

[69]  D. Richman,et al.  In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues , 1997, Journal of virology.

[70]  C. Petito,et al.  Evidence of apoptotic cell death in HIV encephalitis. , 1995, The American journal of pathology.

[71]  S. Lipton.  Neuronal injury associated with HIV-1: approaches to treatment. , 1998, Annual review of pharmacology and toxicology.

[72]  J. Sodroski,et al.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.

[73]  U. de Girolami,et al.  Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. , 1998, The American journal of pathology.

[74]  B. Hyman,et al.  Role of the β-Chemokine Receptors CCR3 and CCR5 in Human Immunodeficiency Virus Type 1 Infection of Monocytes and Microglia , 1998, Journal of Virology.

[75]  L. Foresman,et al.  Simian immunodeficiency virus SIVmac chimeric virus whose env gene was derived from SIV-encephalitic brain is macrophage-tropic but not neurovirulent , 1995, Journal of virology.

[76]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[77]  Howard E. Gendelman,et al.  Dementia Associated with the Acquired Immunodeficiency Syndrome , 1995 .

[78]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[79]  V. Torri,et al.  Elevated cerebrospinal fluid levels of monocyte chemotactic protein‐1 correlate with HIV‐1 encephalitis and local viral replication , 1998, AIDS.

[80]  R. Price.  Neurological complications of HIV infection , 1996, The Lancet.

[81]  E. De Clercq,et al.  CXCR4 as a Functional Coreceptor for Human Immunodeficiency Virus Type 1 Infection of Primary Macrophages , 1998, Journal of Virology.

[82]  W. Streit,et al.  Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[83]  A. Sylwester,et al.  Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency , 1998, Nature Medicine.

[84]  N. Michael,et al.  Host genetic influences on HIV-1 pathogenesis. , 1999, Current opinion in immunology.

[85]  R. Doms,et al.  Chemokine Receptor Utilization by Human Immunodeficiency Virus Type 1 Isolates That Replicate in Microglia , 1998, Journal of Virology.

[86]  V G Sasseville,et al.  Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. , 1996, The American journal of pathology.

[87]  Marc Parmentier,et al.  A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.

[88]  L. Epstein,et al.  Apoptotic neurons in brains from paediatric patients with HIV‐I encephalitis and progressive encephalopathy , 1995, Neuropathology and applied neurobiology.

[89]  T. Schwartz,et al.  Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. , 1997, Science.

[90]  E. Holmes,et al.  In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop , 1994, Journal of virology.

[91]  A. Fauci,et al.  CCR5 Signal Transduction in Macrophages by Human Immunodeficiency Virus and Simian Immunodeficiency Virus Envelopes , 2000, Journal of Virology.

[92]  C. Brosnan,et al.  Cytokine Induction of MIP-1α and MIP-1β in Human Fetal Microglia , 1998, The Journal of Immunology.

[93]  Bin Wang,et al.  Unique HIV type 1 V3 region sequences derived from six different regions of brain: region-specific evolution within host-determined quasispecies. , 1998, AIDS research and human retroviruses.

[94]  Cairns Js,et al.  Current Evidence and Future Directions for Targeting HIV Entry: Therapeutic and Prophylactic Strategies , 2000 .

[95]  E. De Clercq,et al.  Differential signalling of the chemokine receptor CXCR4 by stromal cell‐derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes , 2000, The European journal of neuroscience.

[96]  Takayuki Itoh,et al.  Microglia Express CCR5, CXCR4, and CCR3, but of These, CCR5 Is the Principal Coreceptor for Human Immunodeficiency Virus Type 1 Dementia Isolates , 1999, Journal of Virology.

[97]  R. Doms,et al.  An Orphan Seven-Transmembrane Domain Receptor Expressed Widely in the Brain Functions as a Coreceptor for Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus , 1998, Journal of Virology.

[98]  R. Doms.  Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. , 2000, Virology.

[99]  J. Moore,et al.  Viral phenotype and CCR5 genotype , 1999, Nature Medicine.

[100]  J. Sodroski,et al.  Apelin, the Natural Ligand of the Orphan Seven-Transmembrane Receptor APJ, Inhibits Human Immunodeficiency Virus Type 1 Entry , 2000, Journal of Virology.

[101]  B. Chesebro,et al.  Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences , 1994, Journal of virology.

[102]  M. Weinand,et al.  Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. , 1999, The American journal of pathology.

[103]  Masahiko Kuroda,et al.  Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development , 1998, Nature.

[104]  J. Verhoef,et al.  Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines. , 2000, Journal of neurovirology.

[105]  O. Nishimura,et al.  A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[106]  R. Connor,et al.  Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.

[107]  A. Fauci,et al.  Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope. , 1999, Journal of immunology.

[108]  C. Carter,et al.  Fractalkine modulates TNF‐α secretion and neurotoxicity induced by microglial activation , 2000 .

[109]  Hanneke Schuitemaker,et al.  Analysis of the Temporal Relationship between Human Immunodeficiency Virus Type 1 Quasispecies in Sequential Blood Samples and Various Organs Obtained at Autopsy , 1998, Journal of Virology.

[110]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[111]  T. Crawford,et al.  Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood‐brain barrier , 1993, Annals of neurology.

[112]  M. L. Penn,et al.  CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[113]  C. Achim,et al.  Haptoglobin polymorphism, iron metabolism and mortality in HIV infection , 1998 .

[114]  D. Kolson,et al.  Chemokine receptors in the human brain and their relationship to HIV infection. , 1998, Journal of neurovirology.

[115]  R. Doms,et al.  Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. , 1997, Virology.

[116]  Joseph Sodroski,et al.  Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry , 1999, Cell.

[117]  M. Carrington,et al.  Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences. , 1999, Human molecular genetics.

[118]  W. Kelder,et al.  β‐Chemokines MCP‐1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus–associated dementia , 1998 .

[119]  J. Moore,et al.  HIV-1 entry inhibitors: Evading the issue , 1999, Nature Medicine.

[120]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[121]  Hassan Mohammad Naif,et al.  Persistent CCR5 Utilization and Enhanced Macrophage Tropism by Primary Blood Human Immunodeficiency Virus Type 1 Isolates from Advanced Stages of Disease and Comparison to Tissue-Derived Isolates , 1999, Journal of Virology.

[122]  B. Korber,et al.  Genetic and Functional Analysis of Full-Length Human Immunodeficiency Virus Type 1 env Genes Derived from Brain and Blood of Patients with AIDS , 2003, Journal of Virology.

[123]  B. Korber,et al.  Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences , 1994, Journal of virology.

[124]  Bernhard Moser,et al.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.

[125]  M. Mack,et al.  Aminooxypentane-RANTES Induces CCR5 Internalization but Inhibits Recycling: A Novel Inhibitory Mechanism of HIV Infectivity , 1998, The Journal of experimental medicine.

[126]  I. Campbell,et al.  Chemokines in the CNS: plurifunctional mediators in diverse states , 1999, Trends in Neurosciences.

[127]  R. Doms,et al.  Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses , 1997, Journal of virology.

[128]  J. Sodroski,et al.  CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia , 1997, Nature.

[129]  J. Moore,et al.  AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor , 1998, Nature Medicine.

[130]  P. Crino,et al.  Functional expression of the seven-transmembrane HIV-1 co-receptor APJ in neural cells. , 2000, Journal of neurovirology.

[131]  R. Horuk,et al.  Chemokine and chemokine receptor expression in the central nervous system. , 1999, Journal of neurovirology.

[132]  R. Klein,et al.  Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. , 1999, Journal of immunology.

[133]  T L Hoffman,et al.  Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[134]  J. Vincent,et al.  Human immunodeficiency virus type 1 and its coat protein gp 120 induce apoptosis and activate JNK and ERK mitogen‐activated protein kinases in human neurons , 1997, Annals of neurology.

[135]  J. Fitzgibbon,et al.  Effect of the HIV‐1 syncytium‐inducing phenotype on disease stage in vertically‐infected children , 1998, Journal of medical virology.

[136]  Ying Sun,et al.  Two Orphan Seven-Transmembrane Segment Receptors Which Are Expressed in CD4-positive Cells Support Simian Immunodeficiency Virus Infection , 1997, The Journal of experimental medicine.

[137]  R. Bergamaschi,et al.  Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies , 2001, Journal of Neuroimmunology.

[138]  C. Cicala,et al.  HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[139]  R. Doms,et al.  Structure-function studies of the HIV-1 coreceptors. , 1998, Seminars in immunology.

[140]  M. McGrath,et al.  Unique monocyte subset in patients with AIDS dementia , 1997, The Lancet.

[141]  V. Lévy,et al.  Neuronal apoptosis in human immunodeficiency virus infection. , 2000, Journal of neurovirology.

[142]  H. Gendelman,et al.  Mononuclear phagocytes mediate blood‐brain barrier compromise and neuronal injury during HIV‐1‐associated dementia , 2000, Journal of leukocyte biology.

[143]  M. Kavanaugh,et al.  gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[144]  D. Littman,et al.  Expression cloning of new receptors used by simian and human immunodeficiency viruses , 1997, Nature.

[145]  D. Ho,et al.  In Vivo Distribution of the Human Immunodeficiency Virus/Simian Immunodeficiency Virus Coreceptors: CXCR4, CCR3, and CCR5 , 1998, Journal of Virology.

[146]  C. Combadière,et al.  Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. , 1998, The Journal of biological chemistry.

[147]  S. Spector,et al.  The CCR5Delta32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment. , 2000, The Journal of infectious diseases.

[148]  A. Trkola,et al.  Enhancement of Human Immunodeficiency Virus Type 1 Infection by the CC-Chemokine RANTES Is Independent of the Mechanism of Virus-Cell Fusion , 1999, Journal of Virology.

[149]  T. Molitor,et al.  Differential production of and migratory response to beta chemokines by human microglia and astrocytes. , 1997, The Journal of infectious diseases.

[150]  R. Doms,et al.  The CC Chemokine I-309 Inhibits CCR8-dependent Infection by Diverse HIV-1 Strains* , 1998, The Journal of Biological Chemistry.

[151]  R. Maki,et al.  Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. , 1999, Journal of immunology.

[152]  J. Schlessinger,et al.  Signal Transduction Due to HIV-1 Envelope Interactions with Chemokine Receptors CXCR4 or CCR5 , 1997, The Journal of experimental medicine.

[153]  K. Peden,et al.  STRL33, A Novel Chemokine Receptor–like Protein, Functions as a Fusion Cofactor for Both Macrophage-tropic and T Cell Line–tropic HIV-1 , 1997, The Journal of experimental medicine.

[154]  R. Doms,et al.  Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. , 1998, Virology.

[155]  Michael Greenberg,et al.  Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4 , 1998, Current Biology.

[156]  J. Sodroski,et al.  Adaptation of a CCR5-Using, Primary Human Immunodeficiency Virus Type 1 Isolate for CD4-Independent Replication , 1999, Journal of Virology.

[157]  M. Weinand,et al.  A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. , 1997, Journal of immunology.

[158]  G. Baltuch,et al.  Microglia as mediators of inflammatory and degenerative diseases. , 1999, Annual review of neuroscience.

[159]  B. Brew,et al.  The relationship between AIDS dementia complex and the presence of macrophage tropic and non-syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid. , 1996, Journal of neurovirology.

[160]  Stuart A. Lipton,et al.  Pathways to neuronal injury and apoptosis in HIV-associated dementia , 2001, Nature.

[161]  Hui-yu Liu,et al.  A Putative G Protein-Coupled Receptor, RDC1, Is a Novel Coreceptor for Human and Simian Immunodeficiency Viruses , 2000, Journal of Virology.

[162]  H. Gendelman,et al.  Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. , 1996, Journal of immunology.

[163]  Jianbin Wang,et al.  Chemokine receptors and virus entry in the central nervous system. , 1999, Journal of neurovirology.

[164]  J. Gutiérrez-Ramos,et al.  Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation , 1997, Nature.